Stephen C. Peterson
Partner @ Foresite Capital
Waitsfield, United States
Stephen C. Peterson is a Series B investor at Foresite Capital in Waitsfield focused on Medical and Health Care. Stephen Peterson is a member of the Foresite Capital investment team.Stephen has more than nine years of investment analysis experience in both equity and debt securities.Prior to joining Foresite Capital in 2011, Stephen was the Founder and President of SCP Capital Advisors, a sub-advisor for money management firms and early-stagecompanies. Prior to founding SCP, Stephen worked as an analyst for Palo Alto Investors, a fundamental long/short equity hedge fund in Silicon Valley. Stephen started his career as an analyst with Wells Fargo.In addition to his work with Foresite Capital, Stephen is the Co-founder and Board Member of Yuwa, an Indian-based non-profit organization. He has also served as a guest lecturer on financial modeling and investment analysis at the University of Denver's Daniels College of Business, UC Berkeley's Haas School of Business and San Francisco State University. Stephen is a CFA Charterholder. He is a member of the CFA Institute and the CFA Society of San Francisco. Stephen graduated from the University of Denver with a B.S.B.A. in finance and accounting.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Stephen C. Peterson invests in
Stages Stephen C. Peterson invests in
Countries Stephen C. Peterson invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 1 (100%)
- Health Care 1 (100%)
- Medical Device 1 (100%)
- Personal Health 1 (100%)
- Health Diagnostics 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Sollis Health, formerly known as Priority Private Care (PPC), offers members access to medical facilities, including best-in-class ER physicians who manage their care from check-in to follow-up, superior staff to attend to a member’s every need, advanced diagnostic imaging, VIP support from leading hospitals, and fast access to our hand-selectedspecialist network. The company specializes in concierge urgent and emergency care, functioning similarly to having a personal doctor available at all times. | $33M / Series B / Dec 05, 2024 |
Co-Investors
About Foresite Capital
Foresite Capital is a healthcare and life sciences investment firm. They take a data-driven approach to invest in startups that employ biology and big data to improve healthcare, such as 10x Genomics, Relay Therapeutics, Element Biosciences, and Inscripta.
Foresite Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Dorothy Margolskee
Managing Director
|
|||
James Tananbaum
Founder and CEO
|
|||
|
Stephen C. Peterson
Partner
|
|||
Dennis D. Ryan
CFO & Managing Director
|
|||
|
Elizabeth Liz Canis
Senior Advisor
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Stephen C. Peterson invest in?
Stephen C. Peterson invests primarily in Medical, Health Care and Medical Device startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Stephen C. Peterson?
Public channels for Stephen C. Peterson include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Stephen C. Peterson last invest?
The most recent investment recorded for Stephen C. Peterson closed in Dec 2024. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
